Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4201–4250 of 35129
On March 7, 2025, Anne G. Waleski advised Enact Holdings, Inc. (the “Company”) and the Company’s Board of Directors (the “Board”) of her intention not to stand for re-election as a director of the Company when her term expires at the Company’s upcoming 2025 Annual Meeting of Stockholders on May 14, 2025.
On March 11, 2025, the Board of Directors (the “Board”) of Enact Holdings, Inc., a Delaware Corporation (the “Corporation” or “Enact”), appointed H. Elizabeth Mitchell to serve as a director for a term expiring at the 2025 Annual Meeting of Stockholders.
On March 7, 2025, the Board of Directors (the “Board”) of Cardinal Health, Inc. (the “Company”) elected Robert W. Musslewhite and Sudhakar Ramakrishna to the Board, effective immediately.
On March 7, 2025, the Board of Directors (the “Board”) of Cardinal Health, Inc. (the “Company”) elected Robert W. Musslewhite and Sudhakar Ramakrishna to the Board, effective immediately.
On March 7, 2025, the Board (i) increased the size of the Board from eight to nine members by adding a Class I directorship and (ii) appointed Eric V. Roegner as a Class I director, effective immediately, to fill the Class I directorship vacancy resulting from the increase of the size of the Board with his initial term expiring at the 2025 annual meeting of stockholders of the Company ("2025 Annual Meeting").
On March 8, 2025, the Board of Directors (the “Board”) of UNITY Biotechnology, Inc. (“Unity” or the “Company”) appointed Dr. Yehia Hashad, M.D., current executive vice president of research & development and chief medical officer at Bausch + Lomb, to the Board and as a member of the Science Committee, effective immediately.
approved the appointment of Joseph J. Whalen as a member of the Board, effective as of March 10, 2025.
On March 9, 2025, Guillaume Pepy notified the Board of Directors (the “Board”) of The Chemours Company (the “Company”) of his decision not to seek re-election to the Board at the Company’s 2025 Annual Meeting of Shareholders, when his current term expires.
On March 6, 2025, the Board of Directors (the “Board”) of DexCom, Inc. (“Dexcom”) increased the size of the Board to eleven directors and appointed Renée Galá as a director effective immediately.
Mr. Bilotto succeeds John G. Murray as a Managing Trustee, who resigned effective March 9, 2025
On March 7, 2025, Mr. Brian N. Hansen, a member of our Board of Directors (the “Board”), notified us of his decision not to stand for re-election at our upcoming 2025 annual meeting of stockholders scheduled for May 15, 2025 (the “2025 Annual Meeting”).
On March 6, 2025 (the “Effective Date”), Mark J. Frohlich was appointed to serve on the board of directors (the “Board”) of Rigel Pharmaceuticals, Inc.
On March 10, 2025, the Board of Directors ("Board") of Exelon Corporation (“Exelon”) appointed David DeWalt as an independent director of Exelon, effective immediately.
On March 7, 2025, the Board of Directors (the “Board”) of Senti Biosciences, Inc. (the “Company”) approved the appointment of Feng Hsiung to the Board, pursuant to the terms of a letter agreement dated as of December 2, 2024, by and between the Company and Celadon Partners SPV 24.
elected Mary Hentges to the Board, effective March 5, 2025, to fill the new vacancy on the Board.
On March 9, 2025, Mr. Davidson was appointed as a member of the Board, effective as of March 14, 2025.
On March 5, 2025, Peter Harwin, a member of the Board, notified the Company of his decision to resign as a member of the Board effective as of March 10, 2025.
appointed Christopher Cain, Ph.D., the Director of Research at Fairmount Funds Management LLC, to serve as a Class I director of the Company, chairperson of the Nominating and Corporate Governance Committee, and member of the Audit Committee and Science & Technology Committee, effective as of March 10, 2025.
On March 10, 2025, the Board of Directors (the “Board”) of PayPal Holdings, Inc. (the “Company”) appointed Joy Chik as a new member of the Company’s Board, effective March 10, 2025.
appointed Erin L. Russell as a Class II director on the Board of the Company, effective March 7, 2025.
On March 7, 2025, Jeffrey T. Diehl, a member of the Board of Directors (the "Board") of Q2 Holdings, Inc. (the "Company") notified the Company of his decision not to stand for reelection at the Company’s 2025 annual meeting of stockholders.
On January 7, 2025, the Board of Directors of Crona Corp. (the “Company”) appointed Cheung Lam Hung to fill a vacancy on the Board of Directors with a term expiring at the Company's next Annual Meeting of Stockholders.
As previously disclosed, Ms. Feng also provided her resignation as a member of the Board of Directors on January 25, 2025, effective upon the earlier of (a) 8:00 a.m. Pacific Standard Time on the date that is six months from the date of the Resignation Letter (July 25, 2025); and (b) the date and time that Board of Directors of the Company appoints a Chief Financial Officer, and as such, Ms. Feng’s resignation date as a member of the Board of Directors will also be the day after the Filing Date.
On March 7, 2025, Geoffrey Gwin, Stephanie Kilkenny and Robert Grammen resigned as directors and Mr. Gwin resigned as Chief Executive Officer of the Company.
the remaining directors appointed Nicholas Liuzza, Jr. and Steve Romano to fill two vacancies on the Board of Directors.
the remaining directors appointed Nicholas Liuzza, Jr. and Steve Romano to fill two vacancies on the Board of Directors.
On March 7, 2025, Geoffrey Gwin, Stephanie Kilkenny and Robert Grammen resigned as directors and Mr. Gwin resigned as Chief Executive Officer of the Company.
the Board appointed Mr. Krishna Vanka as the director, Chief Executive Officer and President of the Company and Flux Power, effective March 10, 2025
On March 10 2025, Mr. Ronald F. Dutt notified the board of directors (the “Board”) of Flux Power Holdings, Inc. (the “Company”) of his decision to retire and resign from his position as director, Chairman of the Board, Chief Executive Officer and President of the Company and its wholly owned subsidiary, Flux Power, Inc. (“Flux Power”), effective March 10, 2025
on March 6, 2025, the Company’s board of directors appointed Roy Golan as a Class I director to replace Mr. Elmaliah, effective immediately.
As a then member of the board of directors of the Company, Mr. Elmaliah stepped down as a member of the board and all committees of the board of directors of the Company.
Amy Griffith informed the Board of Directors of the Company that she will not be standing for reelection and is resigning from the Board as of the Annual Meeting.
Effective March 7, 2025, pursuant to the Merger Agreement, Fresh Vine’s board of directors expanded the size of the board from 4 to 5 directors and filled the newly created vacancy by appointing Aaron Day, the Chief Executive Officer of Amaze, to serve on the board.
Effective as of March 6, 2025, Messrs. Carl Stuart Agren resigned as Director of TechCom Inc. (the "Company"), Sheharyar Haider Malhi resigned as Director of the Company, Charles Faulkner resigned as the Chief Executive Officer, of the Company, and Simon Wajcenberg resigned as the Chief Financial Officer, and Secretary of the Company.
Effective as of March 6, 2025, Messrs. Carl Stuart Agren resigned as Director of TechCom Inc. (the "Company"), Sheharyar Haider Malhi resigned as Director of the Company, Charles Faulkner resigned as the Chief Executive Officer, of the Company, and Simon Wajcenberg resigned as the Chief Financial Officer, and Secretary of the Company.
Additionally, the Board has appointed Mr. C. Park Shaper to serve as Chairman and Mr. Mathews to serve as a Class I director.
and resigned as a Class I director of the Board.
On March 7, 2025, James Murren notified the Board of Directors (“Board”) of PLAYSTUDIOS, Inc. (the “Company”) of his resignation as a director of the Company and member of each committee of the Board, effective March 7, 2025.
On March 7, 2025, Victor L. Crawford, Lead Independent Director of The Hershey Company (the “Company”), notified the Company of his intention not to stand for re-election as a director at the Company’s 2025 Annual Meeting of Stockholders, currently expected to be held on May 6, 2025.
On March 3, 2025, Rudolph I. Estrada notified the Board of Directors of East West Bancorp, Inc. (the “Company”) of his decision to retire as a director of the Company, effective immediately.
On March 3, 2025, Jewett-Cameron Trading Company Ltd. (the “Company”) was advised by Mr. Chris Karlin of his intention to resign as a director of the Company’s Board of Directors and each of the Audit Committee and Compensation Committee effective March 31, 2025.
Messrs. Thompson and Poneman promptly accepted these offers, and were appointed as Class III directors
Messrs. Thompson and Poneman promptly accepted these offers, and were appointed as Class III directors
appointed Michael Goller to the Board, effective immediately.
On March 4, 2025, Julia M. Brown notified the Board of Directors of Molson Coors Beverage Company (the “Company”) of her intent to retire as a Class A Director of the Company effective upon the end of her term at the Company’s 2025 Annual Meeting of Stockholders, allowing her to devote more time to her global philanthropic work.
Mr. Michael C. Child, a member of the of the Board of Directors of IPG Photonics Corporation (the " Company "), informed the Company on March 6, 2025 that he will not stand for re-election at the 2025 annual meeting of stockholders.
five new directors were appointed to the Board, including Michael Max Bühler, Stephen Kukucha, Jamila Piracci, Ray Quintana and Thomas G. Anderson.
On November 7, 2024, Mr. Quintana and Mr. Anderson resigned from the Board as chairman and director and as director, respectively, and Wray Thorn was appointed chairman of the Board.
five new directors were appointed to the Board, including Michael Max Bühler, Stephen Kukucha, Jamila Piracci, Ray Quintana and Thomas G. Anderson.
five new directors were appointed to the Board, including Michael Max Bühler, Stephen Kukucha, Jamila Piracci, Ray Quintana and Thomas G. Anderson.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.